Twinbeech Capital LP Heron Therapeutics, Inc. Transaction History

Twinbeech Capital LP

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	BUY	$2.3 - $6.29 $916,947 - $2.51 Million	398,673 New	398,673 $1.11 Million
Q4 2021 Feb 14, 2022	SELL	$8.35 - $12.6 $151,694 - $228,904	-18,167 Closed	0 $0
Q3 2021 Nov 15, 2021	BUY	$10.13 - $15.0 $184,031 - $272,505	18,167 New	18,167 $194,000
Q3 2020 Nov 16, 2020	SELL	$13.67 - $17.77 $295,764 - $384,471	-21,636 Closed	0 $0
Q2 2020 Aug 14, 2020	BUY	$10.89 - $21.47 $235,616 - $464,524	21,636 New	21,636 $318,000

175

121M

80.4K

94.9K

Ticker HRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 118,774,000
Market Cap $202M
Description
Heron Therapeutics, Inc., a biotechnology company, engages in developing treatments to address unmet patient needs. The company's product candidates utilize its proprietary Biochronomer, a drug delivery technology, which delivers therapeutic levels of a range of short-acting pharmacological agents over a period from days to weeks with a single a...

Get notified when there are updates to the investment portfolio of Twinbeech Capital LP, based on Form 13F filings with the SEC.

Stay updated on Twinbeech Capital LP with notifications on news.